ReviewFrontiers in neurology2014
The case for angioplasty in patients with symptomatic intracranial atherosclerosis.
Review in Frontiers in neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 17 citations in OpenAlex.
- Peri-procedural stroke or death in stenting of symptomatic severe intracranial stenosis.Journal of neurointerventional surgery · 2020Trial
- Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis.Stroke · 2015Trial
- Update in the treatment of intracranial atherosclerotic disease.Stroke and vascular neurology · 2020Review
- A review of the diagnosis and management of vertebral basilar (posterior) circulation disease.Surgical neurology international · 2018Review
- The Different Facets of Dyslipidemia and Hypertension in Atherosclerosis.Current atherosclerosis reports · 2016Review
- Stenting in Intracranial Stenosis: Current Controversies and Future Directions.Current atherosclerosis reports · 2015Review
- Matrix metalloproteinase 9 level as an indicator for restenosis following cervical and intracranial angioplasty and stenting.Neural regeneration research · 2015Article
- Editorial: Balloon and Stent for Ischemic and Hemorrhagic Stroke: A New Trend for Stroke Prevention and Management.Frontiers in neurology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intracranial atherosclerotic disease (ICAD) is likely the most common cause of stroke worldwide and remains highly morbid even with highly monitored medical therapy. Recent results of the SAMMPRIS trial, which randomized patients to stenting plus aggressive medical management versus aggressive medical management alone have shown that additional treatment of intracranial atherosclerotic lesions with the Wingspan stent is inferior to aggressive medical management alone. In light of these results, there has been renewed interest in angioplasty alone to treat symptomatic ICAD. This article will briefly review the natural history of ICAD and discuss the possible future for endovascular treatment of ICAD with primary intracranial angioplasty in appropriately selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.